Selected article for: "risk factor and statistical significance"

Author: Helvaci, Nafiye; Eyupoglu, Nesrin Damla; Karabulut, Erdem; Yildiz, Bulent Okan
Title: Prevalence of Obesity and Its Impact on Outcome in Patients With COVID-19: A Systematic Review and Meta-Analysis
  • Cord-id: cnl56oxp
  • Document date: 2021_2_25
  • ID: cnl56oxp
    Snippet: BACKGROUND AND OBJECTIVE: Obesity has been reported as a risk factor for adverse outcomes in COVID-19. However, available studies presenting data on obesity prevalence in patients with COVID-19 have conflicting results. The objective of this systematic review and meta-analysis is to evaluate the prevalence of obesity in these patients and to stratify the estimates by illness severity. METHODS: We performed a literature search with the use of Medline/PubMed and Google Scholar database from Decemb
    Document: BACKGROUND AND OBJECTIVE: Obesity has been reported as a risk factor for adverse outcomes in COVID-19. However, available studies presenting data on obesity prevalence in patients with COVID-19 have conflicting results. The objective of this systematic review and meta-analysis is to evaluate the prevalence of obesity in these patients and to stratify the estimates by illness severity. METHODS: We performed a literature search with the use of Medline/PubMed and Google Scholar database from December 1, 2019 to June 27, 2020 and systematically reviewed studies reporting the number of obese patients with real-time reverse transcriptase polymerase chain reaction (rRT-PCR)-confirmed SARS-CoV-2 infection. RESULTS: Nineteen studies were identified. The pooled obesity prevalence rates were 0.32 (95% CI: 0.24–0.41) in hospitalized patients, 0.41 (95% CI: 0.36–0.45) in patients admitted to intensive care unit, 0.43 (95% CI: 0.36–0.51) in patients needing invasive mechanic ventilation (IMV), and 0.33 (95% CI: 0.26–0.41) in those who died. Obesity was associated with a higher risk for hospitalization [Odds ratio (OR): 1.3, 95% CI: 1.00–1.69; I(2) 52%, p = 0.05], ICU admission (OR: 1.51, 95% CI: 1.16–1.97; I(2) 72%, p = 0.002), and IMV requirement (OR: 1.77, 95% CI: 1.34–2.35; I(2) 0%, p < 0.001). The increase in risk of death did not reach statistical significance (OR: 1.28, 95% CI: 0.76–2.16, p = 0.35) which might be due to obesity survival paradox and/or unidentified factors. CONCLUSIONS: Our data indicate that obese subjects may be at higher risk for serious illness if infected and obesity may play a role in the progression of COVID-19.

    Search related documents:
    Co phrase search for related documents
    • aberrant cytokine activation and adaptive innate immunity: 1
    • abstract title and acute respiratory distress syndrome: 1
    • acute respiratory distress syndrome and adaptive innate: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute respiratory distress syndrome and adaptive innate immunity: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
    • acute respiratory distress syndrome and adipose tissue: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • acute respiratory distress syndrome and admission hospitalization: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute respiratory distress syndrome and admit patient: 1
    • acute respiratory distress syndrome and local prevalence: 1
    • acute respiratory distress syndrome and low similar: 1
    • adaptive innate and adipose tissue: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
    • adaptive innate and admission hospitalization: 1, 2, 3, 4, 5
    • adaptive innate immunity and admission hospitalization: 1
    • adipose tissue and admission hospitalization: 1, 2, 3
    • adipose tissue and local prevalence: 1
    • admission hospitalization and local prevalence: 1
    • admission hospitalization and low similar: 1